(-0.09%) 4 550.58 points
(0.04%) 35 430 points
(-0.16%) 14 258 points
(0.81%) $2 063.60
Live Chart Being Loaded With Signals
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States...
|Today's Volume||40 019.00|
|Average Volume||53 798.00|
|EPS||$0 ( 2023-11-14 )|
|Last Dividend||$0 ( N/A )|
|Next Dividend||$0 ( N/A )|
|2023-05-26||Redmile Group, Llc||Buy||40 258||Stock Option (Right to Buy)|
|2023-05-26||Lee Michael Stewart||Buy||40 258||Stock Option (Right to Buy)|
|2023-05-26||Boudreau Helen M||Buy||40 258||Stock Option (Right to Buy)|
|2023-05-26||Golumbeski George||Buy||40 258||Stock Option (Right to Buy)|
|2023-05-26||Gibson Neil W||Buy||40 258||Stock Option (Right to Buy)|
|Last 99 transactions|
|Buy: 1 930 617 | Sell: 932 277|
Shattuck Labs, Inc. Correlation
|10 Most Positive Correlations|
|10 Most Negative Correlations|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shattuck Labs, Inc. Financials
|Gross Profit:||$652 000 (100.00 %)|
|Gross Profit:||$686 000 (100.00 %)|
|Gross Profit:||$200 000 (100.00 %)|
|Gross Profit:||$57 000.00 (100.00 %)|
Shattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.